Skip to content

The short-term and long-term clinical effects of orthokeratology with modified reverse curve design

The short-term and long-term clinical effects of orthokeratology with modified reverse curve design

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118942
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

RC-Optimized Design Group:RC-optimized orthokeratology wear
Standard Design Group:Standard orthokeratology wear

Sponsors

Tianjin Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. The age is greater than 8 years and less than 12 years; 2. Spherical power: -0.75 D to -4.50 D (both eyes); Astigmatism: WTR = 2:1; Best-corrected visual acuity >= 1.0 (each eye); 3. Anisometropia (SER) <= 1.00 D; 4. They were volunteered to participate, and signed informed consent by the subjects themselves or their legal guardians

Exclusion criteria

Exclusion criteria: 1. History of corneal surgery within the past year; 2. Eyelid abnormalities or infections; 3. Clinically significant slit-lamp examination findings (specific requirements detailed in Protocol Appendix III); 4. Any other active ocular disease; 5. Endothelial cell density 21 mmHg, or an interocular IOP difference >= 5 mmHg); 9. Specific ocular conditions: acute or chronic ocular inflammation, vernal keratoconjunctivitis, glaucoma, or use of medication for dry eye within the past 30 days; 10. Concurrent use of therapeutic ophthalmic drops, including antibiotics, corticosteroids, or compound eye drops containing corticosteroids; 11. Use of any medication that may affect ocular health or contact lens wear; 12. Flat corneal curvature (K) 48.00 D; 13.History of orthokeratology or rigid gas permeable contact lens wear within the past 30 days (including trial participants) or participation in soft hydrophilic contact lens trials within the past 10 days; 14. Participation in any drug clinical trial within the past 90 days; 15. History of allergy to contact lenses and/or lens care products; 16. Examination findings indicating contraindications or unsuitability for orthokeratology lens wear; 17. Only one eye meeting the inclusion criteria; 18. Inability to attend regular follow-up eye examinations (or, for minors, inability of a guardian to accompany them regularly); 19. Any other reason the investigator considers the subject unsuitable for participation.

Design outcomes

Primary

MeasureTime frame
Efficacy rate, defined as achieving uncorrected visual acuity >=0.8 and residual refraction (in spherical equivalent) within +/-0.50 D;Visual Quality Questionnaire;

Secondary

MeasureTime frame
Axial length;Intraocular pressure;Contrast Sensitivity;Corneal endothelial cell parameters;Wavefront aberration;Retinal Defocus;

Countries

China

Contacts

Public ContactYang Xiaoyan

Tianjin Eye Hospital

yanzitjsykyy@163.com+86 22 2724 0996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026